- Home
- /
- Treatment
- /
- Page 107
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
Autologous or allogeneic limbal epithelial stem cells expanded ex vivo on human amniotic membrane | Ocular surface diseases that are characterized by total limbal stem cell deficiency | TissueTech, Inc.;7000 SW 97th Avenue;Miami, Florida, 33173 | July 14, 2005 | |
Recombinant human lysosomal acid lipase or cholesteryl ester hydrolase | Cholesteryl Ester Storage Disease | Lysosomal Acid Lipase, LLC;Subsidiary of Kentucky BioProcessing, LLC, 3700 Airpark Drive;Owensboro, Kentucky, 42301 | July 14, 2005 | |
Alfentanil | Management of postherpetic neuralgia | Cinergen, LLC;146 Medinah Drive;Blue Bell, Pennsylvania, 19422 | July 8, 2005 | |
SDF-1 (108) Lysine Dlmer | Pediatric osteosarcoma | Chemokine Therapeutics Corporation;190 Agronomy Road (UBC), Suite 405;Vancouver, BC V6T 1Z3 | July 7, 2005 | |
Contulakin-G | Intrathecal treatment of neuropathic pain associated with spinal cord injury | Cognetix, Inc.;421 Wakara Way;Salt Lake City, Utah, 84108 | July 7, 2005 | |
Valproic acid, sodium | Familial adenomatous polyposis | Topotarget A/S;Fruebjergvej 3, DK-2100;Copenhagen | June 24, 2005 | |
Recombinant truncated SPINT2 protease inhibitor | Cystic fibrosis | Aerovance, Inc.;2929 Seventh Street;Berkeley, California, 94710 | June 24, 2005 | |
Liposomal annamycin | Acute lymphoblastic leukemia | Callisto Pharmaceuticals, Inc.;420 Lexington Avenue;New York, New York, 10170 | June 17, 2005 | |
Liposomal annamycin | Acute myeloid leukemia | Callisto Pharmaceuticals, Inc.;420 Lexington Avenue;New York, New York, 10170 | June 17, 2005 | |
Adenoviral vector expressing Herpes simplex virus thymidine kinase gene | Malignant brain tumors | Advantagene, Inc.;160 Paulson Road;Waban, Massachusetts, 02468 | June 17, 2005 | |
Clotrimazole | Topical treatment of children and adults with pouchitis | AesRx, LLC;275 Grove Street, Suite 2-400;Newton, Massachusetts, 02466 | June 14, 2005 | |
Geneticin | Amoebiasis | ProcesScience, Inc (PSI);117 Woodberry Lane;Fayetteville, New York, 13066 | June 6, 2005 | |
Polyethylene glycol-modified uricase | Hyperuricemia in patients with gout refractory to conventional therapy or in whom conventional therapy is contraindicated | EnzymeRx, LLC;17 Arcadian Avenue, Suite 104;Paramus, New Jersey, 07652 | June 6, 2005 | |
Tacrolimus | Prophylaxis of organ rejection in patients receiving heart transplants | Astellas Pharma US, Inc.;Three Parkway North;Deerfield, Illinois, 60015 | June 6, 2005 | |
Iboctadekin | Renal cancer | GlaxoSmithKline LLC;Corporation service Company, Suite 400;Wilmington, Delaware, 19808 | June 3, 2005 | |
Cytomegalovirus DNA vaccine with plasmids expressing pp65 and gB genes | Prevention of clinically significant cytomegalovirus (CMV) viremia, CMV disease and associated complications in at-risk hematopoietic cell transplant and solid transplant populations | Astellas Pharma Global Development, Inc.;1 Astellas Way;Northbrook, Illinois, 60062 | June 3, 2005 | |
Sodium phenylacetate/sodium benzoate 10%/10% Injection | Hepatic encephalopathy | Ucyclyd Pharma, Inc.;7720 N. Dobson Road;Scottsdale, Arizona, 85256 | June 3, 2005 | |
Digitoxin | Cystic fibrosis | Silver Pharmaceuticals;350 Seven Locks Road, Suite 211;Rockville, Maryland, 20854 | May 27, 2005 | |
Cilengitide | Glioma | EMD Serono, Inc.;One Technology Place;Rockland, Massachusetts, 02370 | May 27, 2005 | |
Titanium dioxide and bisoctrizole | For the secondary prevention (prevention of lesional induction) of disorders with UV-A and visible light-induced photosensitivity, specifically Actinic prurigo, Hydroa vacciniforme, Solar urticara (SU), Chronic Actinic Dermatitis (CAD), the cutaneous prophyrias, Smith-Lemli-Optiz Syndrome, and Hartnup's Disease | Orfagen;CRDPF - LANGLADE, 31035 Toulouse Cedex; | May 25, 2005 | |
Glyceryl tri (4-phenylbutyrate) | Spinal muscular atrophy | Ucyclyd Pharma, Inc;Subsidiary of Medicis Pharmaceutical Corporation, 7720 N. Dobson Road;Scottsdale, Arizona, 85256 | May 24, 2005 | |
Human anti-integrin receptor av monoclonal antibody | Patients with angiosarcoma | Janssen Research & Development, LLC;920 Route 202 South;Raritan, New Jersey, 08869 | May 5, 2005 | |
Recombinant human alpha 1-antitrypsin | Bronchopulmonary dysplasia | Arriva Pharmaceuticals, Inc.;1010 Atlantic Avenue;Alameda, California, 94501 | April 28, 2005 | |
L-threonyl-L-prolyl-L-prolyl-L-threonine | Neuropathic pain associated with spinal cord injury | Nyxis Neurotherapies, Inc.;1801 Maple Avenue, Suite 4300;Evanston, Illinois, 60201 | April 26, 2005 | |
Tramadol hydrochloride | Management of postherpetic neuralgia | TheraQuest Biosciences, LLC;146 Medinah Drive;Blue Bell, Pennsylvania, 19422 | April 26, 2005 |